The evidence suggested that the lysosome function was critical for degradation of activated EGFR in VHL-deficient cells, and the increased proteasome-mediated degradation was the major reason that activated EGFR had a shorter half-life in VHL-expressing ccRCC cells. This evidence concerns the gene EGFR and nonpapillary renal cell carcinoma.